Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Todd

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
FEMS Immunology and Medical Microbiology|January 1, 1997
Identification of antigenic sites on staphylococcal enterotoxin B and toxoidA C Wood, J S Chadwick, R S Brehm, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
A randomized trial of two types of adjuvant chemotherapy in radiotherapy-treated patients with clinical stages I and II high-grade non-Hodgkin's lymphomaJ Wagstaff, I Todd, D Deakin, et al.
Acta Diabetologica|November 1, 2005
Alleviation of insulitis and moderation of diabetes in NOD mice following treatment with a synthetic Pseudomonas aeruginosa signal molecule, N-(3-oxododecanoyl)-L-homoserine lactoneD I Pritchard, I Todd, A Brown, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1988
An autoimmune aetiology for hypothyroidism following interferon therapy for breast cancerI S Fentiman, F R Balkwill, B S Thomas, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1984
Immunologic memory to phosphocholine. V. Hybridomas representative of group II antibodies utilize V kappa 1-3 gene(s)I Todd, S P Chang, R M Perlmutter, et al.
Brain, Behavior, and Immunity|September 19, 2016
The application of protein microarray assays in psychoneuroimmunologyK Ayling, T Bowden, P Tighe, et al.
Hematological Oncology|April 1, 1986
Factors affecting remission and survival in patients with advanced Hodgkin's disease treated with MVPPJ Wagstaff, W Steward, M Jones, et al.
Journal of Leukocyte Biology|February 26, 2004
Endothelial monocyte-activating polypeptide-II (EMAP-II): a novel inducer of lymphocyte apoptosisJ C Murray, Y M Heng, P Symonds, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1984
A randomized study comparing chemotherapy alone with chemotherapy followed by radiotherapy in patients with pathologically staged IIIA Hodgkin's diseaseD Crowther, J Wagstaff, D Deakin, et al.
Nature|March 19, 1987
HLA class II induction in human islet cells by interferon-gamma plus tumour necrosis factor or lymphotoxinR Pujol-Borrell, I Todd, M Doshi, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
FEMS Immunology and Medical Microbiology|January 1, 1997
Identification of antigenic sites on staphylococcal enterotoxin B and toxoidA C Wood, J S Chadwick, R S Brehm, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
A randomized trial of two types of adjuvant chemotherapy in radiotherapy-treated patients with clinical stages I and II high-grade non-Hodgkin's lymphomaJ Wagstaff, I Todd, D Deakin, et al.
Acta Diabetologica|November 1, 2005
Alleviation of insulitis and moderation of diabetes in NOD mice following treatment with a synthetic Pseudomonas aeruginosa signal molecule, N-(3-oxododecanoyl)-L-homoserine lactoneD I Pritchard, I Todd, A Brown, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1988
An autoimmune aetiology for hypothyroidism following interferon therapy for breast cancerI S Fentiman, F R Balkwill, B S Thomas, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1984
Immunologic memory to phosphocholine. V. Hybridomas representative of group II antibodies utilize V kappa 1-3 gene(s)I Todd, S P Chang, R M Perlmutter, et al.
Brain, Behavior, and Immunity|September 19, 2016
The application of protein microarray assays in psychoneuroimmunologyK Ayling, T Bowden, P Tighe, et al.
Hematological Oncology|April 1, 1986
Factors affecting remission and survival in patients with advanced Hodgkin's disease treated with MVPPJ Wagstaff, W Steward, M Jones, et al.
Journal of Leukocyte Biology|February 26, 2004
Endothelial monocyte-activating polypeptide-II (EMAP-II): a novel inducer of lymphocyte apoptosisJ C Murray, Y M Heng, P Symonds, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1984
A randomized study comparing chemotherapy alone with chemotherapy followed by radiotherapy in patients with pathologically staged IIIA Hodgkin's diseaseD Crowther, J Wagstaff, D Deakin, et al.
Nature|March 19, 1987
HLA class II induction in human islet cells by interferon-gamma plus tumour necrosis factor or lymphotoxinR Pujol-Borrell, I Todd, M Doshi, et al.
Pageof 11